Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Thean S, Chew"'
Autor:
Thean S. Chew, Nuala R. O'Shea, Gavin W. Sewell, Stefan H. Oehlers, Claire M. Mulvey, Philip S. Crosier, Jasminka Godovac-Zimmermann, Stuart L. Bloom, Andrew M. Smith, Anthony W. Segal
Publikováno v:
Disease Models & Mechanisms, Vol 8, Iss 8, Pp 817-829 (2015)
Crohn's disease (CD) is associated with delayed neutrophil recruitment and bacterial clearance at sites of acute inflammation as a result of impaired secretion of proinflammatory cytokines by macrophages. To investigate the impaired cytokine secretio
Externí odkaz:
https://doaj.org/article/76a40966cdef441c9f341dd421b8e284
Autor:
Ravishankar Sargur, Graeme Wild, Laura Marshall, Laura Thompson, Melissa F Hale, Alison Wright, Gloria S. Z. Tun, Alan J Lobo, Thean S. Chew, AJ Brooks, Kerry H Robinson
Publikováno v:
European Journal of Gastroenterology & Hepatology. 34:295-301
Infliximab dose escalation (DE) can be used in inflammatory bowel disease patient; however, the long-term benefit remains unclear, especially in those with antibodies to infliximab (ATI). The aim was to assess the effect of DE in patients with ATI on
Publikováno v:
Poster presentations.
Autor:
Robert Downey, Gloria S. Z. Tun, Kerry Robinson, Alison Wright, Thean S. Chew, Alan J Lobo, Kirsty Swallow, Kristina Emsell, Ravishankar Sargur, AJ Brooks, Melissa F Hale, Graeme Wild, Laura Marshall
Publikováno v:
GastroHep. 1:214-222
Publikováno v:
Posters.
Autor:
AJ Brooks, Laura Marshall, Rebecca Campbell, Gloria S. Z. Tun, Kerry H Robinson, Thean S. Chew, Laura Thompson, Melissa F Hale, Alan J Lobo
Publikováno v:
Inflammatory Bowel Disease.
Introduction Infliximab (IFX) dose escalation (DE) can be used in patients with inflammatory bowel disease with loss of response (LOR) or subtherapeutic drug levels. However, the long-term benefit of DE remains unclear, especially in those with antib
Autor:
Rachel Cooney, Alexandra Kent, Paul Collins, Thean S. Chew, Veronica Hall, Lyn A. Smith, Shaji Sebastian, Kamal Patel, Aileen Fraser, Melanie Gunn, Christian P. Selinger, Maya Roysam, Georgina Kerry, Jimmy K. Limdi, Aaron Bancil, Jonathan Segal, Helen Steed, Klaartje Kok
Publikováno v:
BMJ Open Gastroenterology, Vol 8, Iss 1 (2021)
BMJ Open Gastroenterology
BMJ Open Gastroenterology
BackgroundThe impact of COVID-19 on pregnant inflammatory bowel disease (IBD) patients is currently unknown. Reconfiguration of services during the pandemic may negatively affect medical and obstetric care. We aimed to examine the impacts on IBD ante
Autor:
Nuala R, O'Shea, Thean S, Chew, Jenny, Dunne, Rebecca, Marnane, Bahman, Nedjat-Shokouhi, Philip J, Smith, Stuart L, Bloom, Andrew M, Smith, Anthony W, Segal
Publikováno v:
Journal of Crohn's & Colitis
Background and Aims: ADAM [A Disintegrin And Metalloproteinase] is a family of peptidase proteins which have diverse roles in tissue homeostasis and immunity. Here, we study ADAM-like DECysin-1 [ADAMDEC1] a unique member of the ADAM family. ADAMDEC1
Publikováno v:
Scandinavian Journal of Gastroenterology. 43:1219-1223
Giardia lamblia is the most common enteric protozoan world-wide. The prevalence varies internationally. Patients with giardiasis typically have diarrhoea but may have atypical symptoms when referred for endoscopy. The purpose of this study was to inv
Autor:
Thean S. Chew, Gavin W. Sewell
Publikováno v:
Secrets of Success: Getting into Academic Medicine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aab2ee5596d5d9316bed30f8fdb70401
https://doi.org/10.1201/b13330-15
https://doi.org/10.1201/b13330-15